About |
DV Biologics LLC is a supplier of human biological tools to academic institutions and pharmaceutical companies engaging in cell and drug based discovery and development. Its mission is to provide biological tools needed to advance the innovation of technology that will ultimately be used to treat or prevent multiple human degenerative disorders and diseases.
DV Biologics offers a diverse range of novel human biological tools and services that can be used to study various human pathological conditions in addition to an expanded product portfolio of cell types and tissue-derived products. Its LIFEbank is a collection of product lines, which include tissue-derived, cell-based, genomics, transcriptomics, and proteomic biological tools produced from a diverse range of human specimens from multiple pathological and genetic states and various developmental stages. The company’s LIFEbank offers the following products & services: LIFEbank Cellular Systems, a line of normal, non-diseased, human-derived primary cells and cultured cells for research; LIFEbank Genomic/Proteomic Systems, which offers customers with reliable, quality products for reproducible results with maximum impact; LIFEbank Disease-Specific Systems, which offers customers disease-specific cells and cultured cells for the most accurate study of particular medical and pharmaceutical research objectives; and LIFEbank Cellutions Media, a line of optimized media products designed specifically for maximum growth and maintenance of human-derived primary and cultured cells. It also provides media options for culture, growth and differentiation of various progenitor cell types.
DV Biologics' program, BIOsource, is designed to provide research and pharmaceutical laboratories with customized biological products for virtually any research need. It offers custom cell characterization and isolation services to companies and research organizations specializing in the field of medicine, cell and tissue engineering, and development of cell regeneration therapies. The company’s BIOsource services include: Growth and maintenance of specific cell types, Sourcing the best cells for iPSC lines, Growth and maintenance of undifferentiated stem cells for in vitro differentiation to hematopoietic, pancreatic, endothelial and neural lineages, Analysis of gene expression patterns during culture and differentiation, etc.
DV Biologics’ BIOsource Genomic Services include: Gene expression profiling (microarray study validation), Copy number determination of DNA or RNA targets, siRNA knockdown validation, Allelic discrimination / SNP genotyping, Transgenic mouse genotyping, Microbial detection, Real-time PCR pluripotency/differentiation assays, etc. The company’s BIOsource Genomic services also offers a pathological screening service where biological specimens may be submitted for detection of Hepatitis B, C, HIV I & II and other viral and bacterial contaminants.
DV Biologics has agreements with System Biosciences (SBI) and Cambridge BioScience, Ltd. It is also an ISO 9001:2008 certified company.
Areas of activity: Analytical and Bioanalytical Services, Contract Research Organizations, Cryopreservation and Other Cell Tissue Services, Discovery and Research Services